|4May 9, 5:11 PM ET

Cockroft Bettina M. 4

4 · CNS Pharmaceuticals, Inc. · Filed May 9, 2023

Insider Transaction Report

Form 4
Period: 2023-05-05
Transactions
  • Award

    Option to purchase common stock

    2023-05-05+8,3008,300 total
    Exercise: $1.67Exp: 2023-05-05Common Stock (8,300 underlying)
Footnotes (2)
  • [F1]The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or May 5, 2023, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
  • [F2]The options were issued in connection with the reporting person's Board of Director services to the Company.

Documents

1 file
  • 4
    ownership.xmlPrimary